Research
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis — in some cases even redirecting the course of care.
Latest stories
Biotherapeutics
April 9, 2024
Health & Wellness
April 4, 2024
Transplant
April 1, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community